← FDA DRUG APPROVALS

FDA ANDA · ANDA086109

TOLBUTAMIDE

Sponsor: WATSON LABS

APPLICATION
ANDA086109
TYPE
ANDA
ORIGINAL APPROVAL
1979-01-30
LATEST ACTION
1998-07-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TOLBUTAMIDEDiscontinued
TOLBUTAMIDE 500MG · TABLET · ORAL

Approval history

1998-07-17Manufacturing (CMC) · Supplement 30AP
1997-05-23Manufacturing (CMC) · Supplement 29AP
1995-07-12Manufacturing (CMC) · Supplement 27AP
1994-08-17Manufacturing (CMC) · Supplement 28AP
1991-01-18Labeling · Supplement 26AP
1988-03-08Manufacturing (CMC) · Supplement 25AP
1987-12-17Manufacturing (CMC) · Supplement 24AP
1987-12-17Manufacturing (CMC) · Supplement 23AP
1986-05-15Manufacturing (CMC) · Supplement 21AP
1984-10-02Manufacturing (CMC) · Supplement 18AP
1983-01-27Manufacturing (CMC) · Supplement 14AP
1983-01-27Manufacturing (CMC) · Supplement 15AP
1979-01-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →